Literature DB >> 22586700

Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.

Ndéye Marième Wade-Gueye1, Maya Boudiffa, Arnaud Vanden-Bossche, Norbert Laroche, Jane E Aubin, Laurence Vico, Marie-Hélène Lafage-Proust, Luc Malaval.   

Abstract

Bone sialoprotein (BSP) is highly expressed in early bone deposition and may play a part in primary bone mineralization. We previously showed that while BSP−/− mice have a mild secondary bone phenotype and are responsive to mechanical (unloading) and hormonal (ovariectomy, parathyroid hormone (PTH)) challenges, repair of a cortical bone defect, which involves primary bone deposition is significantly delayed in these mice. In the present study, we investigated the role of BSP in a pure model of primary bone modeling. Bone marrow was ablated by trans-epiphysis aspiration in the femora of BSP+/+ and BSP−/− mice, and 7 days post surgery μCT analysis showed vigorous new bone formation in the shaft of BSP+/+ animals but much less in BSP−/− mice. After 14 days, the volume of medullary bone was significantly decreased as expected in BSP+/+ mice, while it remained stable in the BSP−/−. Osteoid thickness and surface were higher in BSP−/− at day 7, suggesting delayed mineralization, while osteoclast surface and number were significantly lower at day 14, a stage of high medullary bone resorption. At day 7, mRNA expression of early osteoblast marker genes (RUNX2, osterix, alkaline phosphatase, osteopontin) did not differ between the two genotypes, while markers of terminal differentiation (MEPE, DMP1, osteocalcin) as well as receptor activator of NF-kappaB ligand (RANKL) and tartrate-resistant acid phosphatase (TRAP) were significantly lower in BSP−/− than in BSP+/+ mice. PTH treatment maintained the volume of medullary bone up to 12 days after ablation in BSP+/+ mice, but failed to do so in BSP−/− mice. PTH significantly increased bone formation rate in both genotype, while it reduced osteoclast number and surface in BSP+/+, but not in BSP−/− medullary bone. In summary, medullary bone formation after marrow ablation is blunted in BSP−/− mice, with delayed resorption and impaired response to PTH. These findings confirm the hypothesis of a crucial role for BSP in primary ossification, which has long been suspected for mineralization, but here extends to bone deposition and turnover.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586700     DOI: 10.1016/j.bone.2012.02.014

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein.

Authors:  B L Foster; M Ao; C Willoughby; Y Soenjaya; E Holm; L Lukashova; A B Tran; H F Wimer; P M Zerfas; F H Nociti; K R Kantovitz; B D Quan; E D Sone; H A Goldberg; M J Somerman
Journal:  Bone       Date:  2015-05-09       Impact factor: 4.398

2.  Effects of Yunnan Baiyao on the Differentiation of HPDLFs on the Bio-Oss® Collagen Scaffold in vivo.

Authors:  Xiaohong Yu; Jing Wang; Qianqian Han; Wen Chu; Shaowen Lu; Yu Liu; Yi Peng; Jie Xu; Yanqing Shui
Journal:  Int J Gen Med       Date:  2022-06-03

3.  Mast Cell Mediators Inhibit Osteoblastic Differentiation and Extracellular Matrix Mineralization.

Authors:  William Marcatti Amarú Maximiano; Elaine Zayas Marcelino da Silva; Ana Carolina Santana; Paulo Tambasco de Oliveira; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2017-10-05       Impact factor: 2.479

4.  Proliferation and osteo/odontoblastic differentiation of stem cells from dental apical papilla in mineralization-inducing medium containing additional KH(2)PO(4).

Authors:  L Wang; M Yan; Y Wang; G Lei; Y Yu; C Zhao; Z Tang; G Zhang; C Tang; J Yu; H Liao
Journal:  Cell Prolif       Date:  2013-04       Impact factor: 6.831

5.  The role of bone sialoprotein in the tendon-bone insertion.

Authors:  Ryan Marinovich; Yohannes Soenjaya; Gregory Q Wallace; Andre Zuskov; Andrew Dunkman; Brian L Foster; Min Ao; Kevin Bartman; Vida Lam; Amin Rizkalla; Frank Beier; Martha J Somerman; David W Holdsworth; Louis J Soslowsky; François Lagugné-Labarthet; Harvey A Goldberg
Journal:  Matrix Biol       Date:  2016-01-28       Impact factor: 11.583

6.  17beta-estradiol promotes the odonto/osteogenic differentiation of stem cells from apical papilla via mitogen-activated protein kinase pathway.

Authors:  Yao Li; Ming Yan; Zilu Wang; Yangyu Zheng; Junjun Li; Shu Ma; Genxia Liu; Jinhua Yu
Journal:  Stem Cell Res Ther       Date:  2014-11-17       Impact factor: 6.832

7.  Analysis of Osteoblast Differentiation on Polymer Thin Films Embedded with Carbon Nanotubes.

Authors:  Jin Woo Lee; Jin-Woo Park; Dongwoo Khang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

8.  10(-7)  m 17β-oestradiol enhances odonto/osteogenic potency of human dental pulp stem cells by activation of the NF-κB pathway.

Authors:  Y Wang; Y Zheng; Z Wang; J Li; Z Wang; G Zhang; J Yu
Journal:  Cell Prolif       Date:  2013-10-24       Impact factor: 6.831

9.  The impairment of osteogenesis in bone sialoprotein (BSP) knockout calvaria cell cultures is cell density dependent.

Authors:  Guenaelle Bouet; Wafa Bouleftour; Laura Juignet; Marie-Thérèse Linossier; Mireille Thomas; Arnaud Vanden-Bossche; Jane E Aubin; Laurence Vico; David Marchat; Luc Malaval
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

10.  Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice.

Authors:  R Pacheco-Costa; H M Davis; E G Atkinson; E Katchburian; L I Plotkin; R D Reginato
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-03       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.